trans-2-(2,5-Dimethoxy-4-iodophenyl)cyclopropylamine and trans-2-(2,5-dimethoxy-4-bromophenyl)cyclopropylamine as potent agonists for the 5-HT2 receptor family (original) (raw)

Synthesis and Serotonin Receptor Affinities of a Series of trans -2-(Indol-3-yl)cyclopropylamine Derivatives

David Nichols

Journal of Medicinal Chemistry, 1998

View PDFchevron_right

N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues

David Nichols

ACS chemical neuroscience, 2015

View PDFchevron_right

Cyclopropyl-tryptamine Analogues: Synthesis and Biological Evaluation as 5-HT 6 Receptor Ligands

János Sápi

ChemMedChem, 2013

View PDFchevron_right

Discovery of N-Substituted 2-Phenylcyclopropylmethylamines as Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists for Potential Use as Antipsychotic Medications

alan kozikowski

Journal of medicinal chemistry, 2017

View PDFchevron_right

Structure–Activity Relationship and Evaluation of Phenethylamine and Tryptamine Derivatives for Affinity towards 5-Hydroxytryptamine Type 2A Receptor

SHUJIE WANG

Biomolecules & Therapeutics

View PDFchevron_right

Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents

Patrick Giguere, Oluseye Onajole

Journal of Medicinal Chemistry, 2015

View PDFchevron_right

Selective 5Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action

alan kozikowski

Journal of Medicinal Chemistry, 2009

View PDFchevron_right

1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: A Potent Serotonin 5-HT2A/2C Agonist

David Nichols

Journal of Medicinal Chemistry, 1994

View PDFchevron_right

Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: Definition of its binding profile using agonists, antagonists and inverse agonists

Adrian Newman-Tancredi

Naunyn-Schmiedeberg's Archives of Pharmacology, 1998

View PDFchevron_right

Dibenzofuranylethylamines as 5-HT2A/2C Receptor Agonists

Thirumal Yempala

ACS omega, 2020

View PDFchevron_right

Dibenzofuranylethylamines as 5-HT2A/2C Receptor Agonists

Thirumal Yempala

ACS Omega, 2020

View PDFchevron_right

Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT 1A Receptors

M. Kleven

View PDFchevron_right

2-Substituted Tryptamines: Agents with Selectivity for 5-HT 6 Serotonin Receptors ‖

Sandy J Hufeisen

Journal of Medicinal Chemistry, 2000

View PDFchevron_right

5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines

Bruce Cassels

PLOS ONE, 2019

View PDFchevron_right

New 5-Hydroxytryptamine1A Receptor Ligands Containing a Norbornene Nucleus: Synthesis and in Vitro Pharmacological Evaluation

Paola Massarelli

Journal of Medicinal Chemistry, 2005

View PDFchevron_right

Derivatives of cis-2-Amino-8-hydroxy-1-methyltetralin: Mixed 5-HT1A-Receptor Agonists and Dopamine D2-Receptor Antagonists

Tommy Lewander

Journal of Medicinal Chemistry, 1995

View PDFchevron_right

Dopamine/serotonin receptor ligands. Part 17: A cross-target SAR approach: Affinities of azecine-styled ligands for 5-HT2A versus D1 and D2 receptors

Christoph Enzensperger

Bioorganic & Medicinal Chemistry Letters, 2008

View PDFchevron_right

N -Methyl-5- tert -butyltryptamine: A Novel, Highly Potent 5-HT 1D Receptor Agonist

James Audia

Journal of Medicinal Chemistry, 1999

View PDFchevron_right

Research Letter: Structural Combination of Established 5-HT2A Receptor Ligands: New Aspects of the Binding Mode

Mikael Palner

Chemical Biology & Drug Design, 2010

View PDFchevron_right

C5-Substituted Derivatives of 5-OMe-BPAT: Synthesis and Interactions with Dopamine D2 and Serotonin 5-HT1A Receptors

Martin Tulp

Bioorganic & Medicinal Chemistry, 1999

View PDFchevron_right

Structure-Activity Relationships of Constrained Phenylethylamine Ligands for the Serotonin 5-HT2 Receptors

A. Olma

PLoS ONE, 2013

View PDFchevron_right

Emerging Opportunities and Concerns for Drug Discovery at Serotonin 5- 5-HT 2B Receptors

eduardo dominguez medina

View PDFchevron_right

4-Aryl-Substituted 2,5-Dimethoxyphenethylamines: Synthesis and Serotonin 5-HT2AReceptor Affinities

David Nichols

Chemistry & Biodiversity, 2009

View PDFchevron_right

Comparative receptor mapping of serotoninergic 5-HT3 and 5-HT4 binding sites

bellinda benhamu

Jcamd, 1998

View PDFchevron_right

Binding Properties of Dipropyltryptamine at the Human 5-HT1a Receptor

Ethan B Russo

Pharmacology, 2005

View PDFchevron_right

Design and Discovery of Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists

alan kozikowski

Journal of medicinal chemistry, 2016

View PDFchevron_right

Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist

Linda Liau

Pharmacology Biochemistry and Behavior, 1991

View PDFchevron_right

Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models

William Wetsel

Journal of medicinal chemistry, 2016

View PDFchevron_right

New 5-HT1A receptor ligands containing a N′-cyanoisonicotinamidine nucleus: Synthesis and in vitro pharmacological evaluation

Paola Massarelli

Bioorganic & Medicinal Chemistry Letters, 2010

View PDFchevron_right